nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—glaucoma	0.7	1	CbGaD
Trisalicylate-choline—Magnesium salicylate—PTGS2—glaucoma	0.00146	0.541	CrCbGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00133	0.1	CbGpPWpGaD
Trisalicylate-choline—Salsalate—PTGS2—glaucoma	0.00124	0.46	CrCbGaD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00105	0.0797	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000905	0.0685	CbGpPWpGaD
Trisalicylate-choline—Pain—Latanoprost—glaucoma	0.000727	0.00256	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Methazolamide—glaucoma	0.000724	0.00255	CcSEcCtD
Trisalicylate-choline—Tinnitus—Brinzolamide—glaucoma	0.000719	0.00253	CcSEcCtD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000719	0.0544	CbGpPWpGaD
Trisalicylate-choline—Erythema—Brimonidine—glaucoma	0.000715	0.00252	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Brimonidine—glaucoma	0.0007	0.00247	CcSEcCtD
Trisalicylate-choline—Urticaria—Methazolamide—glaucoma	0.000698	0.00246	CcSEcCtD
Trisalicylate-choline—Dizziness—Metipranolol—glaucoma	0.000693	0.00244	CcSEcCtD
Trisalicylate-choline—Tinnitus—Pilocarpine—glaucoma	0.000691	0.00243	CcSEcCtD
Trisalicylate-choline—Flushing—Pilocarpine—glaucoma	0.000688	0.00242	CcSEcCtD
Trisalicylate-choline—Erythema—Dorzolamide—glaucoma	0.000683	0.0024	CcSEcCtD
Trisalicylate-choline—Erythema—Travoprost—glaucoma	0.00068	0.00239	CcSEcCtD
Trisalicylate-choline—Oedema—Apraclonidine—glaucoma	0.00068	0.00239	CcSEcCtD
Trisalicylate-choline—Pruritus—Diclofenamide—glaucoma	0.000675	0.00238	CcSEcCtD
Trisalicylate-choline—Weight increased—Clonidine—glaucoma	0.000673	0.00237	CcSEcCtD
Trisalicylate-choline—Erythema—Brinzolamide—glaucoma	0.000672	0.00236	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Dorzolamide—glaucoma	0.000669	0.00235	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Travoprost—glaucoma	0.000666	0.00234	CcSEcCtD
Trisalicylate-choline—Rash—Metipranolol—glaucoma	0.000661	0.00233	CcSEcCtD
Trisalicylate-choline—Dermatitis—Metipranolol—glaucoma	0.00066	0.00232	CcSEcCtD
Trisalicylate-choline—Drowsiness—Clonidine—glaucoma	0.00066	0.00232	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Brinzolamide—glaucoma	0.000658	0.00231	CcSEcCtD
Trisalicylate-choline—Headache—Metipranolol—glaucoma	0.000656	0.00231	CcSEcCtD
Trisalicylate-choline—Pruritus—Levobunolol—glaucoma	0.000649	0.00228	CcSEcCtD
Trisalicylate-choline—Asthma—Betaxolol—glaucoma	0.000644	0.00227	CcSEcCtD
Trisalicylate-choline—Dizziness—Carteolol—glaucoma	0.000642	0.00226	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Carbachol—glaucoma	0.000637	0.00224	CcSEcCtD
Trisalicylate-choline—Sweating—Clonidine—glaucoma	0.000632	0.00223	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Pilocarpine—glaucoma	0.000632	0.00222	CcSEcCtD
Trisalicylate-choline—Dizziness—Diclofenamide—glaucoma	0.000631	0.00222	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Levobunolol—glaucoma	0.000628	0.00221	CcSEcCtD
Trisalicylate-choline—Nausea—Metipranolol—glaucoma	0.000622	0.00219	CcSEcCtD
Trisalicylate-choline—Epistaxis—Clonidine—glaucoma	0.000622	0.00219	CcSEcCtD
Trisalicylate-choline—Dizziness—Carbachol—glaucoma	0.000616	0.00217	CcSEcCtD
Trisalicylate-choline—Confusional state—Acetazolamide—glaucoma	0.000613	0.00216	CcSEcCtD
Trisalicylate-choline—Headache—Carteolol—glaucoma	0.000608	0.00214	CcSEcCtD
Trisalicylate-choline—Vomiting—Diclofenamide—glaucoma	0.000607	0.00214	CcSEcCtD
Trisalicylate-choline—Dizziness—Levobunolol—glaucoma	0.000607	0.00213	CcSEcCtD
Trisalicylate-choline—Somnolence—Apraclonidine—glaucoma	0.000604	0.00213	CcSEcCtD
Trisalicylate-choline—Pruritus—Latanoprost—glaucoma	0.000602	0.00212	CcSEcCtD
Trisalicylate-choline—Rash—Diclofenamide—glaucoma	0.000602	0.00212	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Methazolamide—glaucoma	0.000601	0.00212	CcSEcCtD
Trisalicylate-choline—Shock—Acetazolamide—glaucoma	0.000598	0.00211	CcSEcCtD
Trisalicylate-choline—Headache—Diclofenamide—glaucoma	0.000598	0.0021	CcSEcCtD
Trisalicylate-choline—Vomiting—Carbachol—glaucoma	0.000592	0.00208	CcSEcCtD
Trisalicylate-choline—Hepatitis—Clonidine—glaucoma	0.000592	0.00208	CcSEcCtD
Trisalicylate-choline—Hallucination—Clonidine—glaucoma	0.000589	0.00207	CcSEcCtD
Trisalicylate-choline—Rash—Carbachol—glaucoma	0.000587	0.00207	CcSEcCtD
Trisalicylate-choline—Dermatitis—Carbachol—glaucoma	0.000587	0.00207	CcSEcCtD
Trisalicylate-choline—Weight increased—Betaxolol—glaucoma	0.000586	0.00206	CcSEcCtD
Trisalicylate-choline—Somnolence—Bimatoprost—glaucoma	0.000586	0.00206	CcSEcCtD
Trisalicylate-choline—Oedema—Brimonidine—glaucoma	0.000584	0.00205	CcSEcCtD
Trisalicylate-choline—Headache—Carbachol—glaucoma	0.000584	0.00205	CcSEcCtD
Trisalicylate-choline—Constipation—Apraclonidine—glaucoma	0.000581	0.00205	CcSEcCtD
Trisalicylate-choline—Pain—Apraclonidine—glaucoma	0.000581	0.00205	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Bimatoprost—glaucoma	0.00058	0.00204	CcSEcCtD
Trisalicylate-choline—Nausea—Carteolol—glaucoma	0.000577	0.00203	CcSEcCtD
Trisalicylate-choline—Headache—Levobunolol—glaucoma	0.000575	0.00202	CcSEcCtD
Trisalicylate-choline—Shock—Brimonidine—glaucoma	0.000574	0.00202	CcSEcCtD
Trisalicylate-choline—Nausea—Diclofenamide—glaucoma	0.000567	0.002	CcSEcCtD
Trisalicylate-choline—Pain—Bimatoprost—glaucoma	0.000564	0.00198	CcSEcCtD
Trisalicylate-choline—Dizziness—Latanoprost—glaucoma	0.000562	0.00198	CcSEcCtD
Trisalicylate-choline—Confusional state—Dorzolamide—glaucoma	0.000562	0.00198	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Apraclonidine—glaucoma	0.00056	0.00197	CcSEcCtD
Trisalicylate-choline—Vomiting—Methazolamide—glaucoma	0.000559	0.00197	CcSEcCtD
Trisalicylate-choline—Oedema—Dorzolamide—glaucoma	0.000558	0.00196	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Timolol—glaucoma	0.000556	0.00196	CcSEcCtD
Trisalicylate-choline—Oedema—Travoprost—glaucoma	0.000555	0.00195	CcSEcCtD
Trisalicylate-choline—Rash—Methazolamide—glaucoma	0.000554	0.00195	CcSEcCtD
Trisalicylate-choline—Dermatitis—Methazolamide—glaucoma	0.000554	0.00195	CcSEcCtD
Trisalicylate-choline—Nausea—Carbachol—glaucoma	0.000553	0.00195	CcSEcCtD
Trisalicylate-choline—Tinnitus—Clonidine—glaucoma	0.000552	0.00194	CcSEcCtD
Trisalicylate-choline—Sweating—Betaxolol—glaucoma	0.000551	0.00194	CcSEcCtD
Trisalicylate-choline—Headache—Methazolamide—glaucoma	0.00055	0.00194	CcSEcCtD
Trisalicylate-choline—Shock—Dorzolamide—glaucoma	0.000549	0.00193	CcSEcCtD
Trisalicylate-choline—Hypotension—Brimonidine—glaucoma	0.000545	0.00192	CcSEcCtD
Trisalicylate-choline—Nausea—Levobunolol—glaucoma	0.000545	0.00192	CcSEcCtD
Trisalicylate-choline—Epistaxis—Betaxolol—glaucoma	0.000542	0.00191	CcSEcCtD
Trisalicylate-choline—Somnolence—Acetazolamide—glaucoma	0.000541	0.0019	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Dorzolamide—glaucoma	0.000539	0.0019	CcSEcCtD
Trisalicylate-choline—Rash—Latanoprost—glaucoma	0.000536	0.00189	CcSEcCtD
Trisalicylate-choline—Dermatitis—Latanoprost—glaucoma	0.000536	0.00189	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Acetazolamide—glaucoma	0.000535	0.00188	CcSEcCtD
Trisalicylate-choline—Headache—Latanoprost—glaucoma	0.000533	0.00188	CcSEcCtD
Trisalicylate-choline—Anorexia—Dorzolamide—glaucoma	0.000531	0.00187	CcSEcCtD
Trisalicylate-choline—Confusional state—Pilocarpine—glaucoma	0.000531	0.00187	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Acetazolamide—glaucoma	0.000529	0.00186	CcSEcCtD
Trisalicylate-choline—Oedema—Pilocarpine—glaucoma	0.000527	0.00185	CcSEcCtD
Trisalicylate-choline—Asthma—Timolol—glaucoma	0.000526	0.00185	CcSEcCtD
Trisalicylate-choline—Nausea—Methazolamide—glaucoma	0.000522	0.00184	CcSEcCtD
Trisalicylate-choline—Hypotension—Dorzolamide—glaucoma	0.000521	0.00183	CcSEcCtD
Trisalicylate-choline—Somnolence—Brimonidine—glaucoma	0.000519	0.00183	CcSEcCtD
Trisalicylate-choline—Hypotension—Travoprost—glaucoma	0.000519	0.00183	CcSEcCtD
Trisalicylate-choline—Shock—Pilocarpine—glaucoma	0.000518	0.00182	CcSEcCtD
Trisalicylate-choline—Erythema—Clonidine—glaucoma	0.000515	0.00181	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Brimonidine—glaucoma	0.000514	0.00181	CcSEcCtD
Trisalicylate-choline—Hallucination—Betaxolol—glaucoma	0.000513	0.00181	CcSEcCtD
Trisalicylate-choline—Hypotension—Brinzolamide—glaucoma	0.000512	0.0018	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Pilocarpine—glaucoma	0.000509	0.00179	CcSEcCtD
Trisalicylate-choline—Anorexia—Pilocarpine—glaucoma	0.000502	0.00177	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Acetazolamide—glaucoma	0.000501	0.00176	CcSEcCtD
Trisalicylate-choline—Pain—Brimonidine—glaucoma	0.000499	0.00176	CcSEcCtD
Trisalicylate-choline—Somnolence—Dorzolamide—glaucoma	0.000496	0.00174	CcSEcCtD
Trisalicylate-choline—Hypotension—Pilocarpine—glaucoma	0.000492	0.00173	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Dorzolamide—glaucoma	0.000491	0.00173	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Travoprost—glaucoma	0.000489	0.00172	CcSEcCtD
Trisalicylate-choline—Somnolence—Brinzolamide—glaucoma	0.000487	0.00171	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Dorzolamide—glaucoma	0.000485	0.00171	CcSEcCtD
Trisalicylate-choline—Urticaria—Acetazolamide—glaucoma	0.000483	0.0017	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Brinzolamide—glaucoma	0.000482	0.0017	CcSEcCtD
Trisalicylate-choline—Pruritus—Apraclonidine—glaucoma	0.000481	0.00169	CcSEcCtD
Trisalicylate-choline—Tinnitus—Betaxolol—glaucoma	0.000481	0.00169	CcSEcCtD
Trisalicylate-choline—Flushing—Betaxolol—glaucoma	0.000478	0.00168	CcSEcCtD
Trisalicylate-choline—Pain—Dorzolamide—glaucoma	0.000477	0.00168	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Brinzolamide—glaucoma	0.000476	0.00168	CcSEcCtD
Trisalicylate-choline—Constipation—Travoprost—glaucoma	0.000475	0.00167	CcSEcCtD
Trisalicylate-choline—Pain—Travoprost—glaucoma	0.000475	0.00167	CcSEcCtD
Trisalicylate-choline—Pain—Brinzolamide—glaucoma	0.000469	0.00165	CcSEcCtD
Trisalicylate-choline—Somnolence—Pilocarpine—glaucoma	0.000468	0.00165	CcSEcCtD
Trisalicylate-choline—Pruritus—Bimatoprost—glaucoma	0.000466	0.00164	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Apraclonidine—glaucoma	0.000465	0.00164	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Pilocarpine—glaucoma	0.000464	0.00163	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Dorzolamide—glaucoma	0.000459	0.00162	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Pilocarpine—glaucoma	0.000458	0.00161	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Travoprost—glaucoma	0.000457	0.00161	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Brinzolamide—glaucoma	0.000452	0.00159	CcSEcCtD
Trisalicylate-choline—Constipation—Pilocarpine—glaucoma	0.00045	0.00159	CcSEcCtD
Trisalicylate-choline—Pain—Pilocarpine—glaucoma	0.00045	0.00159	CcSEcCtD
Trisalicylate-choline—Sweating—Timolol—glaucoma	0.00045	0.00158	CcSEcCtD
Trisalicylate-choline—Dizziness—Apraclonidine—glaucoma	0.00045	0.00158	CcSEcCtD
Trisalicylate-choline—Erythema—Betaxolol—glaucoma	0.000449	0.00158	CcSEcCtD
Trisalicylate-choline—Urticaria—Dorzolamide—glaucoma	0.000443	0.00156	CcSEcCtD
Trisalicylate-choline—Epistaxis—Timolol—glaucoma	0.000442	0.00156	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Betaxolol—glaucoma	0.000439	0.00155	CcSEcCtD
Trisalicylate-choline—Dizziness—Bimatoprost—glaucoma	0.000436	0.00153	CcSEcCtD
Trisalicylate-choline—Urticaria—Brinzolamide—glaucoma	0.000435	0.00153	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Pilocarpine—glaucoma	0.000434	0.00153	CcSEcCtD
Trisalicylate-choline—Vomiting—Apraclonidine—glaucoma	0.000432	0.00152	CcSEcCtD
Trisalicylate-choline—Dermatitis—Apraclonidine—glaucoma	0.000428	0.00151	CcSEcCtD
Trisalicylate-choline—Headache—Apraclonidine—glaucoma	0.000426	0.0015	CcSEcCtD
Trisalicylate-choline—Confusional state—Clonidine—glaucoma	0.000424	0.00149	CcSEcCtD
Trisalicylate-choline—Oedema—Clonidine—glaucoma	0.000421	0.00148	CcSEcCtD
Trisalicylate-choline—Hallucination—Timolol—glaucoma	0.000419	0.00147	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Acetazolamide—glaucoma	0.000416	0.00146	CcSEcCtD
Trisalicylate-choline—Rash—Bimatoprost—glaucoma	0.000416	0.00146	CcSEcCtD
Trisalicylate-choline—Dermatitis—Bimatoprost—glaucoma	0.000415	0.00146	CcSEcCtD
Trisalicylate-choline—Shock—Clonidine—glaucoma	0.000414	0.00146	CcSEcCtD
Trisalicylate-choline—Pruritus—Brimonidine—glaucoma	0.000413	0.00145	CcSEcCtD
Trisalicylate-choline—Headache—Bimatoprost—glaucoma	0.000413	0.00145	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Clonidine—glaucoma	0.000407	0.00143	CcSEcCtD
Trisalicylate-choline—Nausea—Apraclonidine—glaucoma	0.000404	0.00142	CcSEcCtD
Trisalicylate-choline—Dizziness—Acetazolamide—glaucoma	0.000402	0.00142	CcSEcCtD
Trisalicylate-choline—Anorexia—Clonidine—glaucoma	0.000401	0.00141	CcSEcCtD
Trisalicylate-choline—Pruritus—Dorzolamide—glaucoma	0.000394	0.00139	CcSEcCtD
Trisalicylate-choline—Hypotension—Clonidine—glaucoma	0.000393	0.00138	CcSEcCtD
Trisalicylate-choline—Pruritus—Travoprost—glaucoma	0.000393	0.00138	CcSEcCtD
Trisalicylate-choline—Tinnitus—Timolol—glaucoma	0.000393	0.00138	CcSEcCtD
Trisalicylate-choline—Nausea—Bimatoprost—glaucoma	0.000392	0.00138	CcSEcCtD
Trisalicylate-choline—Pruritus—Brinzolamide—glaucoma	0.000388	0.00136	CcSEcCtD
Trisalicylate-choline—Vomiting—Acetazolamide—glaucoma	0.000387	0.00136	CcSEcCtD
Trisalicylate-choline—Dizziness—Brimonidine—glaucoma	0.000386	0.00136	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Dorzolamide—glaucoma	0.000381	0.00134	CcSEcCtD
Trisalicylate-choline—Headache—Acetazolamide—glaucoma	0.000381	0.00134	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Travoprost—glaucoma	0.00038	0.00134	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Brinzolamide—glaucoma	0.000375	0.00132	CcSEcCtD
Trisalicylate-choline—Somnolence—Clonidine—glaucoma	0.000374	0.00132	CcSEcCtD
Trisalicylate-choline—Pruritus—Pilocarpine—glaucoma	0.000373	0.00131	CcSEcCtD
Trisalicylate-choline—Confusional state—Betaxolol—glaucoma	0.000369	0.0013	CcSEcCtD
Trisalicylate-choline—Dizziness—Dorzolamide—glaucoma	0.000369	0.0013	CcSEcCtD
Trisalicylate-choline—Rash—Brimonidine—glaucoma	0.000368	0.0013	CcSEcCtD
Trisalicylate-choline—Dermatitis—Brimonidine—glaucoma	0.000368	0.00129	CcSEcCtD
Trisalicylate-choline—Dizziness—Travoprost—glaucoma	0.000367	0.00129	CcSEcCtD
Trisalicylate-choline—Erythema—Timolol—glaucoma	0.000367	0.00129	CcSEcCtD
Trisalicylate-choline—Oedema—Betaxolol—glaucoma	0.000366	0.00129	CcSEcCtD
Trisalicylate-choline—Headache—Brimonidine—glaucoma	0.000366	0.00129	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Clonidine—glaucoma	0.000366	0.00129	CcSEcCtD
Trisalicylate-choline—Dizziness—Brinzolamide—glaucoma	0.000362	0.00128	CcSEcCtD
Trisalicylate-choline—Nausea—Acetazolamide—glaucoma	0.000361	0.00127	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Pilocarpine—glaucoma	0.00036	0.00127	CcSEcCtD
Trisalicylate-choline—Shock—Betaxolol—glaucoma	0.00036	0.00127	CcSEcCtD
Trisalicylate-choline—Constipation—Clonidine—glaucoma	0.00036	0.00127	CcSEcCtD
Trisalicylate-choline—Pain—Clonidine—glaucoma	0.00036	0.00127	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Timolol—glaucoma	0.000359	0.00126	CcSEcCtD
Trisalicylate-choline—Vomiting—Dorzolamide—glaucoma	0.000354	0.00125	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Betaxolol—glaucoma	0.000354	0.00125	CcSEcCtD
Trisalicylate-choline—Rash—Dorzolamide—glaucoma	0.000352	0.00124	CcSEcCtD
Trisalicylate-choline—Dermatitis—Dorzolamide—glaucoma	0.000351	0.00124	CcSEcCtD
Trisalicylate-choline—Rash—Travoprost—glaucoma	0.00035	0.00123	CcSEcCtD
Trisalicylate-choline—Dermatitis—Travoprost—glaucoma	0.00035	0.00123	CcSEcCtD
Trisalicylate-choline—Headache—Dorzolamide—glaucoma	0.000349	0.00123	CcSEcCtD
Trisalicylate-choline—Anorexia—Betaxolol—glaucoma	0.000349	0.00123	CcSEcCtD
Trisalicylate-choline—Vomiting—Brinzolamide—glaucoma	0.000348	0.00123	CcSEcCtD
Trisalicylate-choline—Dizziness—Pilocarpine—glaucoma	0.000348	0.00123	CcSEcCtD
Trisalicylate-choline—Headache—Travoprost—glaucoma	0.000348	0.00122	CcSEcCtD
Trisalicylate-choline—Nausea—Brimonidine—glaucoma	0.000347	0.00122	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Clonidine—glaucoma	0.000347	0.00122	CcSEcCtD
Trisalicylate-choline—Rash—Brinzolamide—glaucoma	0.000346	0.00122	CcSEcCtD
Trisalicylate-choline—Dermatitis—Brinzolamide—glaucoma	0.000345	0.00122	CcSEcCtD
Trisalicylate-choline—Headache—Brinzolamide—glaucoma	0.000343	0.00121	CcSEcCtD
Trisalicylate-choline—Hypotension—Betaxolol—glaucoma	0.000342	0.0012	CcSEcCtD
Trisalicylate-choline—Vomiting—Pilocarpine—glaucoma	0.000335	0.00118	CcSEcCtD
Trisalicylate-choline—Urticaria—Clonidine—glaucoma	0.000334	0.00118	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—FN1—glaucoma	0.000333	0.0252	CbGpPWpGaD
Trisalicylate-choline—Rash—Pilocarpine—glaucoma	0.000332	0.00117	CcSEcCtD
Trisalicylate-choline—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.000332	0.0251	CbGpPWpGaD
Trisalicylate-choline—Dermatitis—Pilocarpine—glaucoma	0.000332	0.00117	CcSEcCtD
Trisalicylate-choline—Nausea—Dorzolamide—glaucoma	0.000331	0.00117	CcSEcCtD
Trisalicylate-choline—Headache—Pilocarpine—glaucoma	0.00033	0.00116	CcSEcCtD
Trisalicylate-choline—Nausea—Travoprost—glaucoma	0.00033	0.00116	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CA1—glaucoma	0.000326	0.0247	CbGpPWpGaD
Trisalicylate-choline—Nausea—Brinzolamide—glaucoma	0.000326	0.00115	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Betaxolol—glaucoma	0.000322	0.00113	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Betaxolol—glaucoma	0.000318	0.00112	CcSEcCtD
Trisalicylate-choline—Pain—Betaxolol—glaucoma	0.000313	0.0011	CcSEcCtD
Trisalicylate-choline—Constipation—Betaxolol—glaucoma	0.000313	0.0011	CcSEcCtD
Trisalicylate-choline—Nausea—Pilocarpine—glaucoma	0.000313	0.0011	CcSEcCtD
Trisalicylate-choline—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—glaucoma	0.000309	0.0234	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Betaxolol—glaucoma	0.000302	0.00106	CcSEcCtD
Trisalicylate-choline—Confusional state—Timolol—glaucoma	0.000302	0.00106	CcSEcCtD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000301	0.0228	CbGpPWpGaD
Trisalicylate-choline—Oedema—Timolol—glaucoma	0.000299	0.00105	CcSEcCtD
Trisalicylate-choline—Pruritus—Clonidine—glaucoma	0.000298	0.00105	CcSEcCtD
Trisalicylate-choline—Shock—Timolol—glaucoma	0.000294	0.00104	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000294	0.0222	CbGpPWpGaD
Trisalicylate-choline—Urticaria—Betaxolol—glaucoma	0.000291	0.00102	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Timolol—glaucoma	0.000289	0.00102	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Clonidine—glaucoma	0.000288	0.00101	CcSEcCtD
Trisalicylate-choline—Anorexia—Timolol—glaucoma	0.000285	0.001	CcSEcCtD
Trisalicylate-choline—Hypotension—Timolol—glaucoma	0.00028	0.000984	CcSEcCtD
Trisalicylate-choline—Dizziness—Clonidine—glaucoma	0.000278	0.000979	CcSEcCtD
Trisalicylate-choline—Vomiting—Clonidine—glaucoma	0.000267	0.000941	CcSEcCtD
Trisalicylate-choline—Somnolence—Timolol—glaucoma	0.000266	0.000936	CcSEcCtD
Trisalicylate-choline—Rash—Clonidine—glaucoma	0.000265	0.000934	CcSEcCtD
Trisalicylate-choline—Dermatitis—Clonidine—glaucoma	0.000265	0.000933	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—FN1—glaucoma	0.000264	0.02	CbGpPWpGaD
Trisalicylate-choline—Headache—Clonidine—glaucoma	0.000264	0.000928	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Timolol—glaucoma	0.000263	0.000927	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Timolol—glaucoma	0.00026	0.000915	CcSEcCtD
Trisalicylate-choline—Pruritus—Betaxolol—glaucoma	0.000259	0.000912	CcSEcCtD
Trisalicylate-choline—Pain—Timolol—glaucoma	0.000256	0.000901	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TXN—glaucoma	0.000255	0.0193	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Betaxolol—glaucoma	0.000251	0.000882	CcSEcCtD
Trisalicylate-choline—Nausea—Clonidine—glaucoma	0.00025	0.000879	CcSEcCtD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000247	0.0187	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Timolol—glaucoma	0.000247	0.000868	CcSEcCtD
Trisalicylate-choline—Dizziness—Betaxolol—glaucoma	0.000242	0.000852	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—PTGS2—glaucoma	0.000242	0.0183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000239	0.0181	CbGpPWpGaD
Trisalicylate-choline—Urticaria—Timolol—glaucoma	0.000238	0.000837	CcSEcCtD
Trisalicylate-choline—Vomiting—Betaxolol—glaucoma	0.000233	0.00082	CcSEcCtD
Trisalicylate-choline—Rash—Betaxolol—glaucoma	0.000231	0.000813	CcSEcCtD
Trisalicylate-choline—Dermatitis—Betaxolol—glaucoma	0.000231	0.000812	CcSEcCtD
Trisalicylate-choline—Headache—Betaxolol—glaucoma	0.000229	0.000808	CcSEcCtD
Trisalicylate-choline—Nausea—Betaxolol—glaucoma	0.000218	0.000766	CcSEcCtD
Trisalicylate-choline—Pruritus—Timolol—glaucoma	0.000212	0.000745	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.00021	0.0159	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Timolol—glaucoma	0.000205	0.000721	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000202	0.0153	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Eicosanoid Synthesis—PTGS2—glaucoma	0.0002	0.0152	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Timolol—glaucoma	0.000198	0.000696	CcSEcCtD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000196	0.0149	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Timolol—glaucoma	0.00019	0.00067	CcSEcCtD
Trisalicylate-choline—Rash—Timolol—glaucoma	0.000189	0.000664	CcSEcCtD
Trisalicylate-choline—Dermatitis—Timolol—glaucoma	0.000188	0.000663	CcSEcCtD
Trisalicylate-choline—Headache—Timolol—glaucoma	0.000187	0.00066	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000179	0.0136	CbGpPWpGaD
Trisalicylate-choline—Nausea—Timolol—glaucoma	0.000178	0.000626	CcSEcCtD
Trisalicylate-choline—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000173	0.0131	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000173	0.0131	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000168	0.0127	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000163	0.0124	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.000157	0.0119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.000151	0.0114	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.00014	0.0106	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.00013	0.00981	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000125	0.00946	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTT1—glaucoma	0.000116	0.00875	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000111	0.00844	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.000111	0.00843	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	0.000111	0.00842	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.000104	0.00785	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NGFR—glaucoma	9.51e-05	0.0072	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP1B1—glaucoma	9.2e-05	0.00697	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	8.96e-05	0.00678	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	8.9e-05	0.00674	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	8.82e-05	0.00668	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.6e-05	0.00651	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—BDNF—glaucoma	8.27e-05	0.00626	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	8.24e-05	0.00624	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NARFL—glaucoma	8.1e-05	0.00613	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CA5A—glaucoma	8.1e-05	0.00613	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1A—glaucoma	7.94e-05	0.00601	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	7.45e-05	0.00564	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTM1—glaucoma	7.36e-05	0.00557	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	7.09e-05	0.00537	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	7e-05	0.0053	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.83e-05	0.00517	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA5A—glaucoma	6.43e-05	0.00487	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NARFL—glaucoma	6.43e-05	0.00487	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	6.38e-05	0.00483	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	6.25e-05	0.00473	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	6.14e-05	0.00465	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	5.97e-05	0.00452	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LRP12—glaucoma	5.82e-05	0.0044	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	5.66e-05	0.00429	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	5.63e-05	0.00426	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	5.53e-05	0.00419	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	4.81e-05	0.00365	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	4.79e-05	0.00362	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	4.22e-05	0.00319	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.12e-05	0.00312	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CA1—glaucoma	3.95e-05	0.00299	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MMP9—glaucoma	3.9e-05	0.00296	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CTSA—glaucoma	3.83e-05	0.0029	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	3.8e-05	0.00288	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGFR1OP—glaucoma	3.75e-05	0.00284	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HEYL—glaucoma	3.75e-05	0.00284	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CA2—glaucoma	3.62e-05	0.00274	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.53e-05	0.00268	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.53e-05	0.00268	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA1—glaucoma	3.14e-05	0.00238	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CTSA—glaucoma	3.04e-05	0.0023	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—glaucoma	3.01e-05	0.00228	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA2—glaucoma	2.87e-05	0.00217	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.87e-05	0.00217	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.81e-05	0.00212	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.81e-05	0.00212	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TP53—glaucoma	2.65e-05	0.00201	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TXN—glaucoma	2.55e-05	0.00193	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.39e-05	0.00181	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HDAC9—glaucoma	2.34e-05	0.00177	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.32e-05	0.00176	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.3e-05	0.00174	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.04e-05	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TXN—glaucoma	2.02e-05	0.00153	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTT1—glaucoma	1.98e-05	0.0015	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.85e-05	0.0014	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.83e-05	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.8e-05	0.00136	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.59e-05	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCA1—glaucoma	1.57e-05	0.00119	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP1B1—glaucoma	1.57e-05	0.00119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTT1—glaucoma	1.57e-05	0.00119	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTM1—glaucoma	1.26e-05	0.000953	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN2B—glaucoma	1.26e-05	0.000952	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCA1—glaucoma	1.25e-05	0.000946	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP1B1—glaucoma	1.25e-05	0.000946	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTHFR—glaucoma	1.11e-05	0.000842	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTHFR—glaucoma	1.05e-05	0.000798	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOE—glaucoma	1.04e-05	0.000784	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CAV1—glaucoma	1.03e-05	0.000777	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTM1—glaucoma	9.99e-06	0.000756	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOE—glaucoma	9.81e-06	0.000743	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CAV1—glaucoma	9.72e-06	0.000736	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—BAD—glaucoma	9.14e-06	0.000692	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTHFR—glaucoma	8.83e-06	0.000668	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOE—glaucoma	8.22e-06	0.000622	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CAV1—glaucoma	8.14e-06	0.000617	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NOS3—glaucoma	7.76e-06	0.000587	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS3—glaucoma	7.35e-06	0.000557	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—glaucoma	7.09e-06	0.000537	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN1B—glaucoma	6.37e-06	0.000482	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NOS3—glaucoma	6.16e-06	0.000466	CbGpPWpGaD
